Lipophilicity and serotonin agonist activity in a series of 4-substituted mescaline analogs

Journal of Medicinal Chemistry
1977.0

Abstract

Replacement of the 4-methoxy of mescaline with higher alkyl homologues or with bromine led to increased activity at serotonin receptors in a sheep umbilical artery preparation. This activity appears correlated with lipophilicity, as measured by 1-octanol-water partition coefficients, but drops off when the 4-substituent is about five atoms in length. It is suggested that 3,4,5-trisubhe 2,4,5-substitution pattern.

Knowledge Graph

Similar Paper

Lipophilicity and serotonin agonist activity in a series of 4-substituted mescaline analogs
Journal of Medicinal Chemistry 1977.0
Serotonin receptor affinities of psychoactive phenalkylamine analogs
Journal of Medicinal Chemistry 1980.0
The role of lipophilicity in determining binding affinity and functional activity for 5-HT2A receptor ligands
Bioorganic & Medicinal Chemistry 2008.0
Sulfur analogs of psychotomimetic agents. 30. Ethyl homologs of mescaline and their monothioanalogs
Journal of Medicinal Chemistry 1984.0
Photoelectron spectra of psychotropic drugs. 6. Relationships between physical properties and pharmacological actions of amphetamine analogs
Journal of Medicinal Chemistry 1981.0
.beta.-Adrenoceptor studies. 2. Effects of alkyl substitution on .beta.-adrenoceptor blocking, antiarrhythmic, and local anesthetic activities of 1,1'-(o-phenylenedioxy)bis(3-isopropylamino-2-propanol)
Journal of Medicinal Chemistry 1977.0
Structure-activity relationships for hallucinogenic N,N-dialkyltryptamines: photoelectron spectra and serotonin receptor affinities of methylthio and methylenedioxy derivatives
Journal of Medicinal Chemistry 1982.0
Adrenergic sulfonanilides. 4. Centrally active .beta.-adrenergic agonists
Journal of Medicinal Chemistry 1976.0
2-Methoxyphenylethanolamines, potential .beta.-adrenergic blocking agents
Journal of Medicinal Chemistry 1978.0
Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane
Journal of Medicinal Chemistry 1982.0